Regulation of PD-L1 expression in the tumor microenvironment.

Regulation of PD-L1 expression in the tumor microenvironment.
复制标题

肿瘤微环境中PD-L1表达的调控

DOI:
10.1186/s13045-020-01027-5
复制
发表时间:
2021-01-07
影响因子:
28.5
通讯作者:
Wu K
Wu K
中科院分区:
医学1区
文献类型:
--
作者:
Yi M;Niu M;Xu L;Luo S;Wu K

文献摘要

参考文献

被引文献

相似文献

癌细胞上的程序性死亡配体1 (PD-L1)与免疫细胞上的程序性死亡配体1 (PD-1)相互作用,促进癌症免疫逃逸。对于多种癌症类型,PD-1/PD-L1轴是抗癌免疫反应的主要限速步骤。在这种情况下,阻断PD-1/PD-L1可以使T细胞从耗尽状态中恢复并根除癌细胞。然而,只有一小部分PD-L1阳性患者从α-PD-1/PD-L1治疗中获益。实际上,PD-L1的表达受多种因素的调控,因此PD-L1阳性的意义是不同的。了解PD-L1的调控机制有助于选择患者,提高治疗效果。在这篇综述中,我们主要关注PD-L1在转录、转录后和翻译后水平上的调节因子。此外,我们还讨论了这些实验结果在临床中的潜在应用。
Programmed death-ligand 1 (PD-L1) on cancer cells engages with programmed cell death-1 (PD-1) on immune cells, contributing to cancer immune escape. For multiple cancer types, the PD-1/PD-L1 axis is the major speed-limiting step of the anti-cancer immune response. In this context, blocking PD-1/PD-L1 could restore T cells from exhausted status and eradicate cancer cells. However, only a subset of PD-L1 positive patients benefits from α-PD-1/PD-L1 therapies. Actually, PD-L1 expression is regulated by various factors, leading to the diverse significances of PD-L1 positivity. Understanding the mechanisms of PD-L1 regulation is helpful to select patients and enhance the treatment effect. In this review, we focused on PD-L1 regulators at the levels of transcription, post-transcription, post-translation. Besides, we discussed the potential applications of these laboratory findings in the clinic.
DOI: 10.18632/oncotarget.6530
发表时间: 2015-12-22
期刊: Oncotarget
影响因子: --
作者:
Carbotti G;Barisione G;Airoldi I;Mezzanzanica D;Bagnoli M;Ferrero S;Petretto A;Fabbi M;Ferrini S
通讯作者: Ferrini S
PD-L1 通过 NF-kappa B 途径被 EBV 驱动的 LMP1 上调,并与自然杀伤/T 细胞淋巴瘤的不良预后相关
DOI: 10.1186/s13045-016-0341-7
发表时间: 2016-10-13
影响因子: 28.5
作者:
Bi XW;Wang H;Zhang WW;Wang JH;Liu WJ;Xia ZJ;Huang HQ;Jiang WQ;Zhang YJ;Wang L
通讯作者: Wang L
DOI: 10.1126/science.aac9935
发表时间: 2016-04-08
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Casey SC;Tong L;Li Y;Do R;Walz S;Fitzgerald KN;Gouw AM;Baylot V;Gütgemann I;Eilers M;Felsher DW
通讯作者: Felsher DW
DOI: 10.1158/0008-5472.can-13-0992
发表时间: 2014-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Barsoum, Ivraym B.;Smallwood, Chelsea A.;Graham, Charles H.
通讯作者: Graham, Charles H.
DOI: 10.1038/nature23643
发表时间: 2017-09-07
期刊: Nature
影响因子: 64.8
作者:
Burr ML;Sparbier CE;Chan YC;Williamson JC;Woods K;Beavis PA;Lam EYN;Henderson MA;Bell CC;Stolzenburg S;Gilan O;Bloor S;Noori T;Morgens DW;Bassik MC;Neeson PJ;Behren A;Darcy PK;Dawson SJ;Voskoboinik I;Trapani JA;Cebon J;Lehner PJ;Dawson MA
通讯作者: Dawson MA